JDRF Blog

Recent Articles

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • The Type 1 Diabetes Digital Recipe Box

    August 14, 2019

    When you’re cooking to meet the needs of someone with type 1 diabetes (T1D), whether that be yourself, a family member or...

  • JDRF Hosts 3D Bioprinting Workshop for Type 1 Diabetes

    August 12, 2019

    “The final results should be more mature ‘cellular products’ for beta cell replacement as a functional cure for T1D.” Francesca Spagnoli, Ph.D.,...

  • FDA Breakthrough Therapy Designation for Teplizumab—Based on the First Study to Delay the Onset of T1D for 2+ Years

    August 5, 2019

    The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay...